Skip to content

Development of a model of Tattoo medicine Wisdom for the treatment of Myofascial Pain Syndrome

Development of a model of Tattoo medicine Wisdom for the treatment of Myofascial Pain Syndrome

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
TCTR
Registry ID
TCTR20250517005
Enrollment
30
Registered
2025-05-17
Start date
2025-06-21
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Myofascial Pain Syndrome Upper Back Pain, Traditional Thai Medicine, Herbal Tattoo Therapy

Interventions

The intervention in this study involves the use of a newly developed herbal tattooing technique aimed at treating myofascial pain syndrome in the upper back. The intervention consists of three session
Experimental Procedure/Surgery
Tattoo Medicine Wisdom for the Treatment of Myofascial

Sponsors

Thailand Science Research and Innovation Fund (TSRI)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Aged between 18 and 60 years, both male and female 2. Willing to voluntarily participate and able to comply with follow-up throughout the study 3. Experiencing upper back muscle pain with a pain score between 4 and 6

Exclusion criteria

Exclusion criteria: 1. History of allergy to herbs such as Zingiber cassumunar (Plai), Curcuma longa (Turmeric), menthol, camphor, or borneol 2. Muscle pain in the neck, shoulder, or upper back caused by trauma or accidents 3. Upper back muscle pain with a pain score Greater than or equal to 7 4. Radiating numbness or pain into the arm due to nerve compression 5. Open wounds, chronic ulcers, or contagious skin lesions; injury within the past 24 hours; or surgery within the past month 6. Received treatments that may affect shoulder or upper back pain prior to study participation, such as topical medications, injections, massage, compresses, acupuncture, or physical therapy 7. Diagnosed with autoimmune diseases or dermatological conditions

Design outcomes

Primary

MeasureTime frame
Pain Reduction At 1 week after end of the intervention Numerical Rating Scale,Reduction in Tender Points At 1 week after end of the intervention Manual Algometer

Secondary

MeasureTime frame
Improvement in Range of Motion At 1 week after end of the intervention Goniometer

Countries

Thailand

Contacts

Public ContactWasan Hayeeyahya

Rajamangala University of Technology Srivijaya

wasan.h@rmutsv.ac.th0816318083

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 10, 2026